Standout Papers
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer (2008)
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study (2015)
- The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies (2009)
Immediate Impact
12 from Science/Nature 110 standout
Citing Papers
Colorectal cancer
2024 Standout
Diagnosis and Treatment of Metastatic Colorectal Cancer
2021 Standout
Works of Lorinda Simms being referenced
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
2015 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lorinda Simms | 3449 | 3545 | 837 | 983 | 37 | 5.0k | |
| Mark S. Huberman | 2978 | 3221 | 770 | 1195 | 80 | 4.4k | |
| D. Johnston | 3500 | 3578 | 663 | 1096 | 22 | 5.0k | |
| Mircea Dediu | 4697 | 5031 | 886 | 1570 | 54 | 6.5k | |
| Alex Y. Chang | 2438 | 2637 | 733 | 1119 | 39 | 4.0k | |
| N. Moore | 1921 | 2553 | 1208 | 1711 | 27 | 3.9k | |
| Venice Archer | 3498 | 3528 | 650 | 901 | 16 | 4.6k | |
| David A. Ramies | 2647 | 2817 | 606 | 1195 | 37 | 3.8k | |
| Eng Huat Tan | 4536 | 4646 | 1027 | 1649 | 55 | 6.7k | |
| Helen Mann | 4000 | 4433 | 1192 | 1592 | 89 | 5.9k | |
| Abderrahim Fandi | 3143 | 2958 | 548 | 1053 | 49 | 4.3k |
All Works
Loading papers...